Electromed, Inc.

ELMD ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Operating Activities
Net Income $11.3M $7.5M $5.2M $3.2M $2.3M $2.4M $4.2M $2.0M
Depreciation & Amortization
Depreciation $868.0K $1.0M $789.0K $550.0K $503.0K $477.0K $619.0K $804.6K
Amortization $58.0K $133.0K $52.0K $63.0K $125.0K $133.0K $122.0K $120.6K
Stock-Based Compensation $2.7M $3.1M $1.7M $708.0K $976.0K $1.0M $902.0K $924.1K
Net Cash from Operating Activities $9.7M $11.4M $9.1M $1.3M $-686.0K $3.1M $4.2M $2.6M
Investing Activities
Capital Expenditures $1.3M $262.0K $287.0K $1.6M $1.4M $287.0K $844.0K $1.3M
Business Acquisitions
Net Cash from Investing Activities $-1.3M $-306.0K $-395.0K $-1.7M $-1.5M $-448.0K $-977.0K $-1.4M
Financing Activities
Dividends Paid
Stock Repurchases $3.9M $10.0M $275.0K $153.0K $1.4M $1.1M
Net Cash from Financing Activities $-3.2M $-11.9M $36.0K $-380.0K $-1.5M $-1.2M $-548.0K $-851.2K
Net Change in Cash $5.2M $-793.0K $8.7M $-781.0K $-3.7M $1.4M $2.7M $352.1K
Free Cash Flow $8.4M $11.1M $8.8M $-333.0K $-2.1M $2.8M $3.4M $1.3M
← Newer Page 1 of 2 Older →